Cancer Type | Cohort Source | Cancer ID | Samples | Death Events | Median OS (yrs) | Permission | Link | Data Download |
---|---|---|---|---|---|---|---|---|
Pheochromocytoma and Paraganglioma | TCGA | PCPG | 179 | 6 | NA | Y | TCGA, GDAC | Download |
Prostate adenocarcinoma | TCGA | PRAD | 499 | 10 | NA | Y | TCGA, GDAC | Download |
Sarcoma | TCGA | SARC | 261 | 97 | 5.45 | Y | TCGA, GDAC | Download |
Pancreatic adenocarcinoma | TCGA | PAAD | 185 | 99 | 1.66 | Y | TCGA, GDAC | Download |
Ovarian serous cystadenocarcinoma | TCGA | OV | 591 | 335 | 3.81 | Y | TCGA, GDAC, CPTAC | Download |
Lung squamous cell carcinoma | TCGA | LUSC | 504 | 203 | 4.64 | Y | TCGA, GDAC | Download |
Mesothelioma | TCGA | MESO | 87 | 72 | 1.54 | Y | TCGA, GDAC | Download |
Skin Cutaneous Melanoma | TCGA | SKCM | 470 | 221 | 6.58 | Y | TCGA, GDAC | Download |
Stomach adenocarcinoma | TCGA | STAD | 443 | 162 | 2.86 | Y | TCGA, GDAC | Download |
Uterine Corpus Endometrial Carcinoma | TCGA | UCEC | 548 | 91 | NA | Y | TCGA, GDAC | Download |
Uterine Carcinosarcoma | TCGA | UCS | 57 | 34 | 2.22 | Y | TCGA, GDAC | Download |
Uveal Melanoma | TCGA | UVM | 80 | 23 | 3.82 | Y | TCGA, GDAC | Download |
Adrenocortical carcinoma | TCGA | ACC | 92 | 33 | NA | Y | TCGA, GDAC | Download |
Thyroid carcinoma | TCGA | THCA | 503 | 16 | NA | Y | TCGA, GDAC | Download |
Stomach and Esophageal carcinoma | TCGA | STES | 628 | 236 | 2.58 | Y | TCGA, GDAC | Download |
Testicular Germ Cell Tumors | TCGA | TGCT | 134 | 3 | NA | Y | TCGA, GDAC | Download |
Lung adenocarcinoma | TCGA | LUAD | 522 | 179 | 4.11 | Y | TCGA, GDAC | Download |
Thymoma | TCGA | THYM | 124 | 9 | NA | Y | TCGA, GDAC | Download |
Cholangiocarcinoma | TCGA | CHOL | 45 | 19 | 3.84 | Y | TCGA, GDAC | Download |
Lymphoid Neoplasm Diffuse Large B-cell Lymphoma | TCGA | DLBC | 48 | 9 | 17.60 | Y | TCGA, GDAC | Download |
Esophageal carcinoma | TCGA | ESCA | 185 | 74 | 2.19 | Y | TCGA, GDAC | Download |
Cervical and endocervical cancers | TCGA | CESC | 307 | 71 | 8.48 | Y | TCGA, GDAC | Download |
Breast invasive carcinoma | TCGA | BRCA | 1097 | 151 | 10.81 | Y | TCGA, GDAC, CPTAC | Download |
Liver hepatocellular carcinoma | TCGA | LIHC | 377 | 125 | 4.91 | Y | TCGA, GDAC | Download |
Bladder urothelial carcinoma | TCGA | BLCA | 412 | 178 | 2.84 | Y | TCGA, GDAC | Download |
Glioblastoma multiforme | TCGA | GBM | 595 | 472 | 1.21 | Y | TCGA, GDAC | Download |
Colorectal adenocarcinoma | TCGA | COADREAD | 629 | 124 | 6.94 | Y | GDAC, CPTAC | Download |
Kidney renal papillary cell carcinoma | TCGA | KIRP | 291 | 44 | NA | Y | TCGA, GDAC | Download |
Glioma | TCGA | GBMLGG | 1110 | 595 | 2.05 | Y | TCGA, GDAC | Download |
Brain Lower Grade Glioma | TCGA | LGG | 515 | 123 | 7.29 | Y | TCGA, GDAC | Download |
Kidney renal clear cell carcinoma | TCGA | KIRC | 537 | 175 | 7.57 | Y | TCGA, GDAC | Download |
Acute Myeloid Leukemia | TCGA | LAML | 200 | 109 | 1.34 | Y | TCGA, GDAC | Download |
Pan-kidney cohort | TCGA | KIPAN | 941 | 230 | NA | Y | TCGA, GDAC | Download |
Head and Neck squamous cell carcinoma | TCGA | HNSC | 528 | 218 | 4.75 | Y | TCGA, GDAC | Download |
Kidney Chromophobe | TCGA | KICH | 113 | 11 | NA | Y | TCGA, GDAC | Download |
CPTAC - Lung squamous cell carcinoma | CPTAC | LSCC | 108 | NA | NA | Y | Download | |
CPTAC - Ovarian Cancer Confirmatory Study | CPTAC | OV | 83 | NA | NA | Y | CPTAC | Download |
CPTAC - Glioblastoma | CPTAC | GBM | 99 | NA | NA | Y | CPTAC | Download |
CPTAC - Pancreatic Ductal Adenocarcinoma Discovery Study | CPTAC | PDAC | 140 | NA | NA | Y | CPTAC | Download |
CPTAC - Head-and-neck squamous cell carcinoma | CPTAC | HNSCC | 110 | NA | NA | Y | CPTAC | Download |
CPTAC-ICPC - Combined Lung Adenocarcinoma Cohorts | CPTAC | LUAD | 402 | - | - | N | - | - |
CPTAC - Lung Adenocarcinoma Confirmatory Study | CPTAC | LUAD | 123 | - | - | N | - | - |
CPTAC - Clear Cell Renal Cell Carcinoma Discovery Cohort | CPTAC | CCRCC | 110 | NA | NA | Y | CPTAC | Download |
CPTAC - Breast cancer prospective cohort | CPTAC | BRCA | 122 | NA | NA | Y | CPTAC | Download |
CPTAC - Colon Adenocarcinoma | CPTAC | COAD | 210 | NA | NA | Y | CPTAC | Download |
CPTAC - Uterine Corpus Endometrial Carcinoma | CPTAC | UCEC | 95 | NA | NA | Y | CPTAC | Download |
CPTAC - Lung adenocarcinoma | CPTAC | LUAD | 110 | NA | NA | Y | CPTAC | Download |
CPTAC pancan - Head-and-neck squamous cell carcinoma | CPTAC-pancan | HNSCC | 108 | 34 | 2.00 | Y | CPTAC, PDC | Download |
CPTAC pancan - Glioblastoma | CPTAC-pancan | GBM | 98 | 69 | 1.12 | Y | CPTAC, PDC | Download |
CPTAC pancan - Lung squamous cell carcinoma | CPTAC-pancan | LSCC | 108 | 25 | 2.80 | Y | CPTAC, PDC | Download |
CPTAC pancan - Ovarian Cancer | CPTAC-pancan | OV | 83 | 7 | 0.98 | Y | CPTAC, PDC | Download |
CPTAC pancan - Uterine Corpus Endometrial Carcinoma | CPTAC-pancan | UCEC | 94 | 10 | 2.32 | Y | CPTAC, PDC | Download |
CPTAC pancan - Pancreatic Ductal Adenocarcinoma | CPTAC-pancan | PDAC | 105 | 75 | 1.19 | Y | CPTAC, PDC | Download |
CPTAC pancan - Colon Adenocarcinoma cohort | CPTAC-pancan | COAD | 109 | 7 | 1.00 | Y | CPTAC, PDC | Download |
CPTAC pancan - Lung adenocarcinoma | CPTAC-pancan | LUAD | 110 | 24 | 1.31 | Y | CPTAC, PDC | Download |
CPTAC pancan - Breast cancer prospective cohort | CPTAC-pancan | BRCA | 122 | 2 | 1.03 | Y | CPTAC, PDC | Download |
CPTAC pancan - Clear Cell Renal Cell Carcinoma | CPTAC-pancan | CCRCC | 103 | 20 | 2.84 | Y | CPTAC, PDC | Download |
PDX Breast Cancer (BCM_PDX_BRCA 2021) | PDX | BRCA | 94 | - | - | N | - | - |
PDX - Breast Cancer (TW) | PDX | BRCA | 16 | - | - | N | - | - |
Breast cancer ER+ PDX | PDX | BRCA | 22 | - | - | N | - | - |
PDX - Breast Cancer | PDX | BRCA | 37 | - | - | N | - | - |
CellLine Colorectal adenocarcinoma | CL | COADREAD | 44 | - | - | N | - | - |
Brain Metastatic Lung Cancer - Lung adenocarcinoma | BMLC | LUAD | 18 | - | - | N | - | - |
Liverpool - Non-Small Cell Lung Cancer | Liverpool | NSCLC | 194 | - | - | N | - | - |